| Revenue growth | FY26 turnover at INR 2,140 Cr. |
|---|---|
| Margins | EBITDA margin improved from 6.8% to 10.6% over three years. |
| Demand visibility | Strong; driven by rising demand for nutritious food. |
| Management confidence | High; emphasis on transformation to integrated solution provider. |
Growth
B2C share of premium products rose from 51% (FY23) to 58% (FY26). Gross margin improved 840 bps to 31.5%.
Outlook
FY27 product launches planned including Granuvia and Spinoace. Company targets sustainable value through manufacturing prowess and expanded R&D.
Risks
Challenges include lesser arable land and need for smart farming practices to maintain efficiency.
Last quarter's promises, checked
Delivered
- Guided 25+ products over 3 years → delivered 25+ products (= BEAT)
- Guided Maharatna/Focused share 60-63% → delivered 60-63% (= BEAT)
- Guided FY26 Revenue Growth → delivered 7% YoY growth (= BEAT)
Partly delivered
- Guided 10% export share → delivered 5% (= PARTIAL)
- Guided 120-day WC cycle → delivered 140-150 days (= PARTIAL)
Missed
- Guided PAT growth → delivered slight decline from INR 142Cr to INR 139Cr (= MISS)
Investor Presentation filed with NSE, NSE: INSECTICID. Summary written with AI assistance from the document.
Insecticides (India) Ltd: key numbers
- Share price
- ₹602.50
- Market cap
- ₹1,753 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 14.0×Sector 37.5×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Board Meeting Date
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.
Insecticides (India) Earnings Call Transcript: Key Takeaways
Q1FY27 was impacted by delayed monsoons, shifting demand later. Despite revenue decline, gross margins improved due to premiumization and inventory management, though EBITDA softened on negative operating leverage.
- Call
- Guides 100% growth
Insecticides (India) Q1 FY27 Results: Net Profit ₹43.9 Cr, Down 24.4% YoY
Insecticides (India) Ltd reported revenue from operations of ₹611.5 Cr (-11.5% YoY) and net profit of ₹43.9 Cr (-24.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹43.9 Cr · -24.4% YoY
Insecticides (India) Earnings Call: Key Takeaways
IIL delivered FY26 revenue of ₹2,140cr (up 7%) with EBITDA of ₹227cr. Strategy focuses on premiumization via the Kaeros brand and R&D partnerships with Nissan and Corteva.
Insecticides (India) Earnings Call: Key Takeaways
Insecticides India delivered steady 7% revenue growth in FY26, balancing raw material inflation through premiumization and strategic partnerships while preparing for a major brand expansion via its new subsidiary, Kairos.
Insecticides (India) Earnings Call: Key Takeaways
Insecticides (India) reported FY26 turnover of ₹2,140 Cr. Company shifting toward premiumization with B2C premium product share rising from 51% (FY23) to 58% (FY26).